Robeauté raises $28M for neurosurgical microrobots for neurology, medicine's final frontier

Robeauté has created a self-propelled microrobot, just 1.8 millimeters long—approximately the size of a grain of rice—that can travel inside the human brain to assist neurosurgeons. The company is targeting tissue sample collection for biopsies as its first use case, but Robeauté hopes it has designed its robot to be a cargo-agnostic carrier that could eventually be used to deliver cancer drugs directly to otherwise inoperable and hard-to-treat brain tumors or implant electrodes deep inside the brain to provide treatments for Parkinson’s or other brain disorders.